Idiopathic pulmonary arterial hypertension and congenital heart defects: similarities and differences

Objective: to study the clinical and pathogenetic features of idiopathic pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension (PAH) in congenital heart defects, based on a 10-year follow-up of patients in the Rostov region. Materials and methods: the analysis included patients over the age of 18 who are registered in the Rostov region with various etiologies of PAH, including with IPAH and PAH-CHD. Two groups of patients were identified: 1st – patients with IPAH (n=32) and 2nd – with PAH in congenital septal heart defects (defects of the atrial or interventricular septa) (n=30). All patients underwent electrocardiography, echocardiography, and condition assessment using the clinical condition assessment scale, as well as the effectiveness of a screening questionnaire for early diagnosis of PAH. Results: it was found that patients with IPAH are older, seek medical help more often, have more pronounced clinical symptoms compared to patients in the 2nd group, and require more aggressive treatment. Patients with PAH in congenital heart defects are less likely to seek help, and have a longer period from the onset of the first symptoms to the detection of pulmonary hypertension. Patients in group 1 required increased PAH-specific therapy in 53% of cases, and patients in group 2 – in 19% (p<0.05). Conclusions: clinical and pathogenetic features of idiopathic PAH and against PAH in congenital heart defects have been identified, which makes it possible to optimize the early diagnosis and treatment of such patients

1. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. https://doi.org/10.1183/13993003.01913-2018

2. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618- 3731. Erratum in: Eur Heart J. 2023;44(15):1312. https://doi.org/10.1093/eurheartj/ehac237.

3. Chazova IY, Martynyuk TV, Valieva ZS, Gratsianskaya SY, Aleevskaya AM, et al. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry. Biomed Res Int. 2020;2020:6836973. https://doi.org/10.1155/2020/6836973

4. Chazova I.E., Martynyuk T.V., Shmalts A.A., Gramovich V.V., Danilov N.M., et al. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023). Eurasian heart journal. 2024;(1):6-85. (In Russ.) https://doi.org/10.38109/2225-1685-2024-1-6-85

5. Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm Circ. 2021;11(1):2045894020977300. https://doi.org/10.1177/2045894020977300

6. Pektas A, Pektas BM, Kula S. An epidemiological study of paediatric pulmonary hypertension in Turkey. Cardiol Young. 2016;26(4):693-697. https://doi.org/10.1017/S1047951115001043

7. Chang KY, Duval S, Badesch DB, Bull TM, Chakinala MM, et al. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. J Am Heart Assoc. 2022;11(9):e024969. https://doi.org/10.1161/JAHA.121.024969

8. Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E. The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension. Systemic Hypertension. 2014;11(4):62-67. eLIBRARY ID: 22808067 EDN: TFCVLL

9. Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E. The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2016;13(1):34-38. (In Russ.) eLIBRARY ID: 26001737 EDN: VWZXCB

10. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1 Suppl):14S-34S. https://doi.org/10.1378/chest.126.1_suppl.14S

11.